Invo BioScience - 53 Year Dividend History | INVO

Historical dividend payout and yield for Invo BioScience (INVO) since 1971. The current TTM dividend payout for Invo BioScience (INVO) as of May 17, 2024 is $0.00. The current dividend yield for Invo BioScience as of May 17, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.003B $0.003B
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.
Stock Name Country Market Cap PE Ratio